Login to Your Account

Takeda Settling in Russia with $96M Manufacturing Facility

By Nuala Moran
Staff Writer

Tuesday, September 11, 2012
LONDON – Takeda Pharmaceutical Co Ltd. is celebrating the completion of its €75 million (US$96 million) manufacturing facility in Russia, becoming one of the first international pharmaceutical companies to put down roots in that important emerging market.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription